Foreign Aid: Difference between revisions

Line 31:

[https://www.devex.com/news/deep-dive-the-unraveling-of-usaid-110584 | Devex | Devex | August 4, 2025]

This article traces how the foreign aid freeze and review process led to the dismantling of much of USAID’s work. It explains the confusion created by stop-work orders, waivers, canceled programs, and staff reductions, showing how the cuts affected the entire aid system rather than only a few isolated projects.

~~=====The Human Cost of Cutting Global Health Aid=====~~

For more than two decades, U.S. foreign assistance—especially through USAID, PEPFAR, and related global health programs—has played a major role in reducing preventable deaths across low- and middle-income countries. The articles reviewed here describe a broad and consistent pattern: international health aid has helped expand vaccination, HIV treatment, tuberculosis diagnosis, maternal health care, child survival programs, family planning, nutrition, and emergency humanitarian response. When these programs are abruptly reduced or withdrawn, the consequences are not abstract budget changes. They can be measured in lives lost, infections left untreated, children unvaccinated, mothers without safe delivery care, and health systems suddenly forced to absorb responsibilities they are not prepared or financed to carry.

The central article, “Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030,” argues that USAID-supported programs helped prevent tens of millions of deaths between 2001 and 2021. Its projection that more than 14 million additional deaths could occur by 2030 if cuts continue gives the aid debate a stark moral and public-health dimension. The issue is not simply whether foreign aid is generous or politically popular. The issue is whether the world is willing to allow preventable mortality to rise after decades of measurable progress.

A related Lancet Global Health article on humanitarian and development assistance broadens this question beyond USAID alone. It shows that official development assistance as a whole has been deeply connected to mortality reductions in many vulnerable countries. This matters because USAID cuts do not happen in isolation. When the United States reduces aid at the same time that European governments and other donors scale back, recipient countries may face a compounded crisis. Reuters’ reporting on possible U.S. and European aid cuts causing up to 22.6 million additional deaths worldwide reinforces this broader danger. The problem is not just one donor exiting one program; it is the possibility of a synchronized retreat from global health financing.

The disease-specific studies show why the mortality effects could be so large. HIV programs are especially vulnerable because treatment must be continuous. Articles in The Lancet HIV, eClinicalMedicine, The Guardian, AP, UNAIDS, and Nature all describe the danger of cuts to HIV funding, particularly through PEPFAR. If people lose access to antiretroviral therapy, the consequences include rising viral loads, increased transmission, more AIDS-related deaths, and the possible erosion of decades of progress. The Lancet HIV modeling study projects that a major international HIV funding crisis could lead to millions of additional infections and large numbers of HIV-related deaths by 2030. The eClinicalMedicine study on the PEPFAR funding freeze shows that even temporary interruptions in seven sub-Saharan African countries could produce measurable excess deaths and infections. These articles together make a crucial point: HIV programs cannot simply pause and restart without harm. Interruptions themselves can become deadly.

Tuberculosis presents a similar warning. The Lancet Global Health study on donor funding reductions and tuberculosis, the PLOS Medicine study on the household economic burden of TB, and the WHO feature on 2025 funding cuts all show that TB control depends on diagnosis, treatment continuity, and public-health infrastructure. When funding falls, fewer people are screened, diagnosed, and treated. That can increase transmission and worsen drug resistance. The PLOS Medicine article adds another dimension: aid cuts do not only increase disease burden; they can also increase household poverty. Families facing TB may lose income, pay for transportation or private care, and experience catastrophic health costs. In this way, donor cuts can create a cycle in which illness worsens poverty and poverty worsens illness.

Maternal and child health are also central to the projected mortality impact. The Health Policy and Planning article on USAID withdrawal in six African countries estimates a sharp increase in maternal deaths under a no-substitution scenario. This is especially important because maternal mortality is often closely tied to basic health-system capacity: trained birth attendants, emergency obstetric care, transportation, supplies, and referral systems. Oxfam’s analysis of under-five deaths, the Gates Foundation Goalkeepers report, and the MSF statement on U.S. support for Gavi all emphasize the child-survival side of the crisis. If vaccine programs, nutrition services, malaria prevention, and basic child health services are cut, children are among the first to die. These deaths are particularly tragic because many are preventable with relatively inexpensive interventions.

Several articles focus not just on the biological or medical effects of aid cuts, but on the political and ethical meaning of abrupt withdrawal. The Lancet commentary “Global health after USAID cuts” and the article “Legitimate expectations and the abrupt cessation of US aid: a human rights issue?” raise questions about responsibility. If donor countries fund essential health programs for years, health systems and communities begin to rely on them. Governments hire workers, patients begin treatment, clinics structure services, and supply chains are built around expected support. Abruptly ending that support is therefore different from gradually transitioning programs to domestic control. Planned transition can be responsible. Sudden withdrawal can be destabilizing and deadly.

The KFF analysis of the foreign aid freeze explains why replacement funding is difficult. Many low- and middle-income countries depend heavily on U.S. support for HIV, TB, malaria, maternal health, and other core services. Other donors may not have the money, political will, or infrastructure to fill the gap. Domestic governments may want to assume more responsibility but lack the fiscal space to do so quickly. This is why many of the studies use no-substitution or partial-substitution scenarios: they reflect the reality that when USAID or PEPFAR funds disappear, there may be no immediate substitute.

The Center for Global Development articles help translate this into practical terms by asking how many lives U.S. foreign aid saves and updating estimates of lives lost from USAID cuts. These analyses are important because they connect mortality projections to actual spending and obligations. They also help show that the benefits of aid are not vague. Programs for HIV treatment, vaccines, malaria prevention, TB control, humanitarian relief, and maternal-child health have measurable outputs and measurable mortality effects.

Together, these articles support one central conclusion: global health aid has been one of the most effective tools for reducing preventable death, and cutting it abruptly is likely to produce severe human consequences. The projected death toll varies by model, disease area, time period, and assumption, but the direction of the evidence is consistent. Reduced funding means fewer services. Fewer services mean more untreated disease, more infections, more unsafe births, more unvaccinated children, and more preventable deaths.

The debate over foreign aid is often framed as a budgetary or political question, but these articles show that it is also a question of life and death. A responsible approach to aid reform would require careful transition planning, protection of the highest-impact health programs, bridge financing, and coordination with affected countries. Abrupt defunding, by contrast, risks reversing decades of progress and transferring the burden to the poorest communities in the world. The evidence from these articles suggests that the cost of such cuts would not only be measured in dollars saved, but in millions of lives lost.

=====Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030=====

Foreign Aid: Difference between revisions

Kirk (talk | contribs)

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 31: / Line 31: @@
 [https://www.devex.com/news/deep-dive-the-unraveling-of-usaid-110584 | Devex | Devex | August 4, 2025]
   This article traces how the foreign aid freeze and review process led to the dismantling of much of USAID’s work. It explains the confusion created by stop-work orders, waivers, canceled programs, and staff reductions, showing how the cuts affected the entire aid system rather than only a few isolated projects.
-=====The Human Cost of Cutting Global Health Aid=====
- For more than two decades, U.S. foreign assistance—especially through USAID, PEPFAR, and related global health programs—has played a major role in reducing preventable deaths across low- and middle-income countries. The articles reviewed here describe a broad and consistent pattern: international health aid has helped expand vaccination, HIV treatment, tuberculosis diagnosis, maternal health care, child survival programs, family planning, nutrition, and emergency humanitarian response. When these programs are abruptly reduced or withdrawn, the consequences are not abstract budget changes. They can be measured in lives lost, infections left untreated, children unvaccinated, mothers without safe delivery care, and health systems suddenly forced to absorb responsibilities they are not prepared or financed to carry.
- The central article, “Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030,” argues that USAID-supported programs helped prevent tens of millions of deaths between 2001 and 2021. Its projection that more than 14 million additional deaths could occur by 2030 if cuts continue gives the aid debate a stark moral and public-health dimension. The issue is not simply whether foreign aid is generous or politically popular. The issue is whether the world is willing to allow preventable mortality to rise after decades of measurable progress.
- A related Lancet Global Health article on humanitarian and development assistance broadens this question beyond USAID alone. It shows that official development assistance as a whole has been deeply connected to mortality reductions in many vulnerable countries. This matters because USAID cuts do not happen in isolation. When the United States reduces aid at the same time that European governments and other donors scale back, recipient countries may face a compounded crisis. Reuters’ reporting on possible U.S. and European aid cuts causing up to 22.6 million additional deaths worldwide reinforces this broader danger. The problem is not just one donor exiting one program; it is the possibility of a synchronized retreat from global health financing.
- The disease-specific studies show why the mortality effects could be so large. HIV programs are especially vulnerable because treatment must be continuous. Articles in The Lancet HIV, eClinicalMedicine, The Guardian, AP, UNAIDS, and Nature all describe the danger of cuts to HIV funding, particularly through PEPFAR. If people lose access to antiretroviral therapy, the consequences include rising viral loads, increased transmission, more AIDS-related deaths, and the possible erosion of decades of progress. The Lancet HIV modeling study projects that a major international HIV funding crisis could lead to millions of additional infections and large numbers of HIV-related deaths by 2030. The eClinicalMedicine study on the PEPFAR funding freeze shows that even temporary interruptions in seven sub-Saharan African countries could produce measurable excess deaths and infections. These articles together make a crucial point: HIV programs cannot simply pause and restart without harm. Interruptions themselves can become deadly.
- Tuberculosis presents a similar warning. The Lancet Global Health study on donor funding reductions and tuberculosis, the PLOS Medicine study on the household economic burden of TB, and the WHO feature on 2025 funding cuts all show that TB control depends on diagnosis, treatment continuity, and public-health infrastructure. When funding falls, fewer people are screened, diagnosed, and treated. That can increase transmission and worsen drug resistance. The PLOS Medicine article adds another dimension: aid cuts do not only increase disease burden; they can also increase household poverty. Families facing TB may lose income, pay for transportation or private care, and experience catastrophic health costs. In this way, donor cuts can create a cycle in which illness worsens poverty and poverty worsens illness.
- Maternal and child health are also central to the projected mortality impact. The Health Policy and Planning article on USAID withdrawal in six African countries estimates a sharp increase in maternal deaths under a no-substitution scenario. This is especially important because maternal mortality is often closely tied to basic health-system capacity: trained birth attendants, emergency obstetric care, transportation, supplies, and referral systems. Oxfam’s analysis of under-five deaths, the Gates Foundation Goalkeepers report, and the MSF statement on U.S. support for Gavi all emphasize the child-survival side of the crisis. If vaccine programs, nutrition services, malaria prevention, and basic child health services are cut, children are among the first to die. These deaths are particularly tragic because many are preventable with relatively inexpensive interventions.
- Several articles focus not just on the biological or medical effects of aid cuts, but on the political and ethical meaning of abrupt withdrawal. The Lancet commentary “Global health after USAID cuts” and the article “Legitimate expectations and the abrupt cessation of US aid: a human rights issue?” raise questions about responsibility. If donor countries fund essential health programs for years, health systems and communities begin to rely on them. Governments hire workers, patients begin treatment, clinics structure services, and supply chains are built around expected support. Abruptly ending that support is therefore different from gradually transitioning programs to domestic control. Planned transition can be responsible. Sudden withdrawal can be destabilizing and deadly.
- The KFF analysis of the foreign aid freeze explains why replacement funding is difficult. Many low- and middle-income countries depend heavily on U.S. support for HIV, TB, malaria, maternal health, and other core services. Other donors may not have the money, political will, or infrastructure to fill the gap. Domestic governments may want to assume more responsibility but lack the fiscal space to do so quickly. This is why many of the studies use no-substitution or partial-substitution scenarios: they reflect the reality that when USAID or PEPFAR funds disappear, there may be no immediate substitute.
- The Center for Global Development articles help translate this into practical terms by asking how many lives U.S. foreign aid saves and updating estimates of lives lost from USAID cuts. These analyses are important because they connect mortality projections to actual spending and obligations. They also help show that the benefits of aid are not vague. Programs for HIV treatment, vaccines, malaria prevention, TB control, humanitarian relief, and maternal-child health have measurable outputs and measurable mortality effects.
- Together, these articles support one central conclusion: global health aid has been one of the most effective tools for reducing preventable death, and cutting it abruptly is likely to produce severe human consequences. The projected death toll varies by model, disease area, time period, and assumption, but the direction of the evidence is consistent. Reduced funding means fewer services. Fewer services mean more untreated disease, more infections, more unsafe births, more unvaccinated children, and more preventable deaths.
- The debate over foreign aid is often framed as a budgetary or political question, but these articles show that it is also a question of life and death. A responsible approach to aid reform would require careful transition planning, protection of the highest-impact health programs, bridge financing, and coordination with affected countries. Abrupt defunding, by contrast, risks reversing decades of progress and transferring the burden to the poorest communities in the world. The evidence from these articles suggests that the cost of such cuts would not only be measured in dollars saved, but in millions of lives lost.
 =====Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030=====